王艳娇, 朱雅碧, 魏雯佳. 非选择性β受体阻滞剂对晚期慢性肝病炎症因子及预后的影响. 世界华人消化杂志 2021; 29(19): 1110-1117 [DOI: 10.11569/wcjd.v29.i19.1110]
Reader's ID:
03206568
Submitted on:
October 20, 2021, 09:07
Reader Expertise:
Reader’s expertise on the topic of the manuscript
Conflicts-of-Interest Statement:
Does the reader have a conflict of interest?
Reader Comment Standards for Published Articles:
Scientific Quality:
The overall quality of the manuscript, based on the above-listed criteria, should be evaluated and classified according to the following five categories
Language Quality:
Language quality (style, grammar, and spelling) should be evaluated and classified according to the following five categories.
Reader Comments:
多项研究表明, NSBBs还可明显减轻全身性炎症反应, 但尚未明确NSBBs对全身性炎症的抗炎作用是否有助于改善肝硬化患者的临床结局. 因此, 本研究采用竞争风险模型分析NSBBs对晚期慢性肝病炎症因子及预后的影响, 有一定临床指导意义。